201117 Limfa 700x150pix Eng

25 - 26 OCTOBER 2018
HOTEL
"HOLIDAY INN
SOKOLNIKI"
Moscow


201117 Limfa 700x150pix Eng

 

 

Russian Society of Oncohematologists

Russian Medical Academy for Postgraduate Education

 

EVENTS BEFORE THE CONFERENCE

24 октября
12:00 – 17:00
Preliminary Registration for the Conference
14:00 – 16:00
Satellite symposium
17:00 – 19:10
Satellite symposium
 

 

XV RUSSIAN CONFERENCE WITH INTERNATIONAL PARTICIPATION

MALIGNANT LYMPHOMAS

Moscow. October 25-26, 2018

Chair:
I. Poddubnaya
October, 25
08:00 – 09:00
Registration

Session I

15th conference – 15 years in the history of oncohematology
I. Poddubnaya, V. Savchenko
09:00 – 09:20
Irina Poddubnaya
15 years like 1 day
09:20 – 09:35
EHA greeting
Pieter Sonneveld, John Gribben
European hematologic association. Our progress in international collaboration in last 15 years
09:35 – 09:55
Dmitry Sychev
Personalized approach in oncohematological treatments
09:55 – 10:15

Marek Trněný
Oncohematology tomorrow. What do we expect fron the future?

10:15 – 10:30
Vadim Ptushkin
The development of diagnostics and supportive care as the basis for the development of oncology
10:30 – 11:00
Coffee-break

Session II

15th conference – 15 years in the history of oncohematology
L. Mendeleeva, M. Delfogre, E. Terpos
11:00 – 11:10
Larisa Mendeleeva
Мultiple myeloma 15 years ago. Melphalan as the only option to prolong life
11:10 – 11:30
EHA Presentation
Michel Delforge
Multiple myeloma patients - cfndidates for transplantation. Choice for first-line treatment
11:30 – 11:50
Maxim Soloviev
Clinical discussion. Transplant-eligible patients with multiple myeloma. How do we treat them?
11:50 – 12:10
EHA Presentation
Evangelos Terpos
Patients with multiple myeloma not eligible for transplant. How can we prolong their lives?
12:10 – 12:30
Sergey Semochkin
Clinical discussion. Patients with multiple myeloma not eligible for transplant. How do we treat them?
12:30 – 14:00
Lunch
Lunch symposium

Session III

15th conference – 15 years in the history of oncohematology
S. Kravchenko, M. Trněný, G. Tumyan
14:00 – 14:10
Sergey Kravchenko
Non-Hodgkin lymphomas 15 years ago. The start of immunochemotherapies
14:10 – 14:30
Alla Kovrigina
Pathological differential diagnosis of aggressive B-cell lymphomas
14:30 – 14:50
Marek Trněný
Prolonging lives of patients with mantle cell lymphoma. What have we done in last decade and what are our perspectives?
14:50 – 15:10
Lali Babicheva
From antibiotics to monoclonal antibodies or kinase inhibitors. An array of treatment modalities in follicular lymphoma
15:10 – 15:30
Gayane Tumyan
Indolent lymphomas associated with HCV infection
15:30 – 16:00
Coffee-break

Session IV

15th conference – 15 years in the history of oncohematology
B. Afanasiev, T. Pospelova, .E Demina
16:00 – 16:10
Tatiana Pospelova
Hodgkin lymphoma 15 years ago. One-shot disease
16:10 – 16:30
Elena Demina
Can we already use PET-adaptive strategies for Hodgkin lymphoma in real-life setting
16:30 – 17:00
Natalia Mikhailova
The role of autoSCT in Hodgkin lymphoma: how does it change in the era of targeted and immunotherapies
17:00 – 17:30
Boris Afanasiev
AlloSCT in Hodgkin lymphoma: focus on anti-CD30 antibodies and checkpoint inhibitors

 

 

18:00 – 19:00
Poster session excursion with experts
V. Vorobiev, S. Kravchenko, O. Samoilova
 
October, 26
08:00 – 09:00
Registration

Session V

15th conference – 15 years in the history of oncohematology
A. Zaritskey, T Robak, E. Nikitin
09:00 – 09:10
Andrey Zaritskey
CLL 15 years ago. Is there anything better than chlorambucil?
09:10 – 09:30
EHA Presentation
Gianluca Gaidano
How our understanding of CLL pathogenesis is translating into clinical utility
09:30 – 09:50
Eugene Nikitin
How can we improve first-line therapy in CLL?
09:50 – 10:40
Discussion. Relapsed CLL. Different approaches in different patients:
- Olga Samoilova - Late relapse
- Elena Stadnik - Early relapse
- Tadeusz Robak - Refractory after several lines
10:40 – 11:00
Coffee-break
End of poster session vote

Session VI

15th conference – 15 years in the history of oncohematology
V. Ptushkin, G. Gaidano, G. Dudina
11:00 – 11:20
Kamil Kaplanov
Treatment choice – based on the treatment goals and patient’s interests
11:20 – 11:40
Tatiana Konstantinova
Infections in patients with lymphoproliferative diseases – how should can control the risks
11:40 – 12:00
EHA Presentation
Gianluca Gaidano
Novel toxicities in targeted and immunotherapies of lymphomas
12:00 – 12:20
Alexey Kuzmin
Quality of life assessment in clinical trials and in clinical practice – how, when, and why?
12:20 – 12:40
Svetlana Esina
Problems of communication between physician and patient in oncohematological practice
12:40 – 14:10
Lunch
Lunch symposium

Session VII

15th conference – 15 years in the history of oncohematology
V. Melnichenko, S. Semochkin, K. Kaplanov
14:10 – 14:30
Julia Ledovskikh
Treatment standardization and coverage in oncohematological diseases in Russia
14:30 – 14:45
Elena Baryakh
Retrospective study of rituximab biosimilar in Russia
14:45 – 15:00
Best poster presentation
Julia Vinogradova
Role of radiotherapy in patients with relapsed Hodgkin lymphoma (based on recommendations of International Lymphoma Radiation Oncology Group, ILROG)
15:00 – 15:15
Best poster presentation
Anastasia Samoilova
Safety and efficacy of the BeEAC conditioning regimen before autologous stem cell transplantation in relapsed and refractory Hodgkin lymphoma
15:15 – 15:30
Best poster presentation
Svetlana Samarina
The influence of immunohistological subtype and international prognostic index on overall survival in real-life patients with diffuse large B-cell lymphoma
15:30 – 15:45
Best poster presentation
Ekaterina Grishina
Fitst-line treatment of multiple myeloma in patients with dialysis-dependent renal failure
15:45 – 16:00
Closing ceremony

 

 

 

Lunch symposium: